However, by measuring the ventilator‐free days as a primary outcome variable, the researchers concluded that routine use of β2AR agonists did not improve the prognosis in mechanically ventilated ALI patients (NCT 00434993).119, 120. The gene discussed is ADRB2; the disease is acute respiratory distress syndrome.